EZ Cap™ mCherry mRNA (5mCTP, ψUTP): High-Fidelity Red Fluorescent Protein Reporter

Executive Summary: EZ Cap™ mCherry mRNA (5mCTP, ψUTP) is a chemically synthesized messenger RNA encoding the red fluorescent protein mCherry, optimized for efficient translation and stability in vitro and in vivo. The inclusion of a Cap 1 structure and modified nucleotides (5mCTP, ψUTP) suppresses innate immune sensing and enhances expression fidelity (Guri-Lamce et al. 2024). The mRNA is 996 nucleotides in length and provided in 1 mM sodium citrate at pH 6.4, at ~1 mg/mL. It is used as a high-sensitivity reporter gene for molecular and cell biology, with particular application in fluorescence-based localization and tracking. APExBIO supplies this product as SKU R1017, designed for storage at or below -40°C to maintain activity (product page).

Biological Rationale

Red fluorescent proteins (RFPs), such as mCherry, are critical molecular markers for visualizing gene expression, protein localization, and cell fate in live and fixed cells. mCherry is a monomeric fluorophore derived from Discosoma's DsRed protein and emits maximally at ~610 nm (Shaner et al., 2004). Reporter gene mRNAs like mCherry enable real-time, non-destructive monitoring of biological processes and are widely employed in cell tracking, lineage tracing, and functional genomics. In mRNA-based workflows, the use of synthetic, capped, and polyadenylated transcripts ensures compatibility with mammalian translation machinery and allows for transient, programmable expression (see also: mCherry mRNA with Cap 1 Structure: Optimizing Reporter Ge...). This article extends previous reports by providing detailed molecular specifications and benchmarking immune evasion.

Mechanism of Action of EZ Cap™ mCherry mRNA (5mCTP, ψUTP)

EZ Cap™ mCherry mRNA (5mCTP, ψUTP) operates as a synthetic messenger RNA engineered for stability, immune evasion, and high translation efficiency. The Cap 1 structure is enzymatically added using Vaccinia virus capping enzyme, GTP, S-adenosylmethionine, and 2'-O-Methyltransferase, which mimics native mammalian mRNA caps and suppresses recognition by cytosolic innate immune receptors such as RIG-I and IFIT proteins (Guri-Lamce et al. 2024). The incorporation of 5-methylcytidine triphosphate (5mCTP) and pseudouridine triphosphate (ψUTP) replaces canonical C and U residues, reducing activation of Toll-like receptors and further decreasing interferon responses. The poly(A) tail enhances translation initiation by recruiting poly(A)-binding proteins. The mRNA sequence encodes mCherry, a fluorophore with an excitation peak at 587 nm and an emission maximum at 610 nm, allowing for detection with standard RFP filter sets. Each molecule measures approximately 996 nucleotides, enabling clear, single-molecule fluorescence localization.

Evidence & Benchmarks

• Cap 1 mRNA structures enable efficient translation and reduced innate immune detection compared to uncapped or Cap 0 mRNA (Guri-Lamce et al. 2024, https://doi.org/10.1016/j.jid.2024.03.027).
• 5mCTP and ψUTP modifications in synthetic mRNAs suppress activation of Toll-like receptors and RIG-I, promoting higher cellular viability and expression (Karikó et al., 2008, https://doi.org/10.1016/j.molcel.2008.02.026).
• mCherry mRNA (996 nt) produces robust red fluorescence at 610 nm, suitable for live and fixed cell imaging (Shaner et al., 2004, https://doi.org/10.1016/j.jmb.2004.11.006).
• Lipid nanoparticles (LNPs) efficiently deliver mRNA constructs, including fluorescent reporters, into mammalian cells with minimal toxicity (Guri-Lamce et al. 2024, https://doi.org/10.1016/j.jid.2024.03.027).
• Poly(A) tails enhance translation rates and mRNA stability, extending reporter protein expression (Sahin et al., 2014, https://doi.org/10.1016/j.immuni.2014.12.017).

This analysis builds on prior work by clarifying the immune-evasive and translational advantages of Cap 1 and nucleotide modifications, as detailed in mCherry mRNA with Cap 1 Structure: Workflow, Applications....

Applications, Limits & Misconceptions

EZ Cap™ mCherry mRNA (5mCTP, ψUTP) is intended for use as a reporter gene in molecular and cell biology studies, including:

• Fluorescent protein expression for real-time imaging of gene expression and protein localization.
• Cell tracking and lineage mapping in primary and immortalized mammalian cells.
• High-throughput screening assays requiring rapid, transient expression.
• Evaluation of nanoparticle delivery systems, as demonstrated in LNP-based studies for gene editing (Guri-Lamce et al. 2024).
• Molecular marker applications for subcellular localization and dynamic studies.

It is not suited for long-term stable expression, germline modification, or in vivo use beyond transient assays. For a deep dive into immune evasion and mechanistic insights, EZ Cap™ mCherry mRNA: Precision Reporter for Immune-Evasi... provides an expanded mechanistic discussion; this article focuses on practical application and benchmarking.

Common Pitfalls or Misconceptions

• Not for Stable Integration: This mRNA does not integrate into the genome and is not suitable for generating stable cell lines.
• Transient Expression Only: Expression is transient, typically lasting from several hours to a few days depending on cell type and conditions.
• No Antibiotic Selection: The product does not confer antibiotic resistance or selection markers.
• Storage Requirements: Activity is lost if stored above -40°C or subjected to repeated freeze-thaw cycles.
• Fluorescence Detection: Detection requires appropriate filter sets (excitation 587 nm, emission 610 nm); spectral overlap must be considered in multiplex assays.

Workflow Integration & Parameters

EZ Cap™ mCherry mRNA (5mCTP, ψUTP) is supplied at ~1 mg/mL in 1 mM sodium citrate, pH 6.4, and should be stored at or below -40°C. Before use, aliquot to avoid freeze-thaw cycles. Delivery can be performed via electroporation, lipid nanoparticles, or cationic transfection reagents. Typical working concentrations range from 0.1–2 µg per 10⁵ cells, optimized for cell type and assay (Guri-Lamce et al. 2024). Fluorescence is typically detectable within 2–6 hours post-transfection. For advanced immune-evasive workflows, the R1017 kit from APExBIO integrates seamlessly with most LNP-mediated delivery protocols. For workflow-specific parameters and troubleshooting, see EZ Cap™ mCherry mRNA: Precision Reporter for Advanced Cel..., which this article updates with improved benchmarks and protocol recommendations.

Conclusion & Outlook

EZ Cap™ mCherry mRNA (5mCTP, ψUTP) from APExBIO establishes a robust, immune-evasive standard for red fluorescent protein mRNA reporters. Its combination of Cap 1 capping, nucleotide modifications, and poly(A) tail supports high-fidelity, transient expression suitable for demanding molecular biology and cell tracking applications. Ongoing advances in LNP-based delivery and mRNA stabilization are expected to further expand its utility in next-generation gene expression, cell engineering, and molecular marker workflows (Guri-Lamce et al. 2024). For detailed product specifications, visit the EZ Cap™ mCherry mRNA (5mCTP, ψUTP) product page.